Infection of mice with Bacillus Calmette-Guerin (BCG) provided good protection against Babesia species. The intensity and duration of this protection was similar to that established after natural recovery from babesiosis. It developed too soon after the first exposure to the parasite, and was too radioresistant, to be attributable to specific antibody production. In addition, the parasites degenerated within circulating erythrocytes. This phenomenon is inconsistent with phagocytosis or lysis of parasites or parasitized cells, or prevention of entry of parasites into erythrocytes, causing the observed protection. Hence the phenomenon is best explained by the release of a nonspecific mediator that can limit multiplication of parasites within erythrocytes. These results not only throw light on mechanisms of immunity against hemoprotozoa. There are many points of similarity between the nonspecific protection BCG and Corynebacterium parvum provide against Babesia species and inhibition of tumor growth by these agents. Therefore, babesiosis in mice may be a convenient experimental model for assessing stimulation of the mononuclear phagocyte system, which appears to be the basis of nonspecific immunity against bacteria, parasites, and tumors.
Infections with Babesia species greatly increase cattle production cost in certain areas of the world, particularly the wet tropics. Interest in babesiosis in humans has also increased recently (8, 10) . Mice can readily be infected with certain species of both Babesia and Plasmodium, with considerable cross-protection (7) , implying that both these parasites arouse the same defense system. Thus basic information on immunity to babesiosis may also be applicable to malaria.
We have found (4) that infection with Mycobacterium bovis strain Bacillus CalmetteGu6rin (BCG) in appropriate schedules totally protects mice from infection with Babesia microti and B. rodhaini, and from the high parasitemia and death that Plasmodium vinckei causes. This paper expands our earlier report, extending the argument that neither an increased specific immune response nor phagocytosis, but a nonspecific soluble effector substance, is the best explanation for this protection. This may have important implications for our understanding of the protective effect of BCG and Corynebacterium parvum against water to 5 x 107 viable units per ml just before use. Unless otherwise specified, BCG was given intravenously. Thymectomy and splenectomy. Both thymus lobes were removed by aspiration with a water-jet vacuum pump via a midline anterior mediastinal approach. Complete thymectomy was eventually confirmed at autopsy. Splenectomy was performed through a dorsoventral incision high on the left flank, the blood vessels being sealed by electrocautery. Sham operations of both procedures were performed on control mice. In all instances animals were anesthetized with ether and the incisions were closed with a single Michel clip.
Electron microscopy. Several drops of tail blood were fixed in combined glutaraldehyde-osmium tetroxide, postfixed in uranyl acetate, and embedded in agar essentially as described by Hirsch and Fedorko (11) . Cut agar blocks were dehydrated in a graded series of ethanol solutions and embedded in Epikote 812 (14) . Thin sections were cut on a Sorvall MT-2 ultramicrotome, stained with alcoholic uranyl acetate (34) followed by lead citrate (20) , and examined in an AEI EM 6B electron microscope. At least 100 parasites were counted in each mouse when estimating the incidence of abnormal forms.
Irradiation. Mice were irradiated by placing them 1 m from a 6Co source installed in an irradiation unit (Pantatron Ltd.), which gave a dose rate of 0.71 rad/s, as calibrated with a chemical dose meter by the National Physical Laboratories.
RESULTS
Time interval between BCG and B. microti infections. Six groups of four to six mice were given 106 B. microti at times ranging from 5 to 180 days after an injection of 2 x 107 BCG. A seventh group was given BCG 5 days after they had received 106 B. microti, 3 days before the parasites were detectable on thin smears. There was no protection when BCG was given after the parasite, even though the infection was not yet patent. The longer the interval between BCG and subsequent infection, the more effectively the parasite was suppressed ( Table 1) . Reconstituted freeze-dried BCG. It was possible that the freeze-drying and reconstitution to which commercial BCG is subjected might alter its ability to protect mice against babesiosis. This was not the case: when 105, 106, or 107 reconstituted BCG were given to three groups of six mice, the results on challenge were the same as when the challenge followed BCG that had never been freeze-dried.
Duration of protection. Various groups of four to six mice, which had been protected against B. microti or B. rodhaini by prior infection with BCG, were kept for long periods and rechallenged. The timing protocols are set out in Fig. 2 . In all cases, 2 x 107 BCG had been given, and each challenge was with 106 parasites. Parasitemias were monitored every 2nd day while parasitemias of controls were above 1% and every 4th day for the rest of the experiment. No greater than trace levels of parasites were ever seen in mice that had received BCG, so we are sure that the continued protection was not due to an undetected recrudescence providing natural immunization. Once protected against babesiosis with BCG no mouse has yet reverted to susceptibility for up to 10 months after the BCG injection.
Intra-erythrocytic death of parasites. Since B. microti die inside circulating erythrocytes when a mouse overcomes the infection naturally (5; I. A. Clark, J. E. Richmond, E. J. Wills, and A. C. Allison, manuscript submitted), it was important to ascertain whether this also occurs in BCG-protected mice. Thus, to produce a parasitemia high enough for the organisms to be examined from the time of injection, 109 B. microti were given to groups of nine mice either infected with 2 x 107 BCG 100 days earlier, recently recovered from B. microti, or previously unexposed to this parasite. Two mice from each group were killed after 12 h, and another two, after 24 h. Phagocytosis of either parasites or parasitized erythrocytes was not seen on impression smears of spleens or livers.
Parasitemias of the remaining animals were followed for a week. The BCG-treated mice disposed of their parasites as rapidly as did the recovered animals (Fig. 3) . Furthermore, erythrocytes on smears from both these resistant groups showed the inclusions that we have demonstrated by electron microscopy studies on recovering mice (5; Clark et al., manuscript submitted) to be degenerate intra-erythrocytic parasites (Fig. 4) .
To study this aspect further, samples of blood from five mice given 2 x 107 BCG 34 days earlier, three mice fully recovered from a primary infection with the parasite, and two control mice, all given 109 B. microti, were examined by electron microscopy. Normal babesias (Fig. 5A ) showed the fine structure described by others (1, 22) . Parasites had begun to degenerate by 12 h in BCG-protected animals, and the number of abnormal organisms was increased after a further 12 h ( f . . -. 1 . I.-.
-.
I t .,. (Table 2 ). In addition, many babesiae developed multiple cytoplasmic membranes without undergoing condensation of the nucleus or cytoplasmic matrix ( Fig. 5D; Table 2 ).
There were also considerably more condensed organisms in animals receiving B. microti after complete recovery from an initial infection than in controls given the same large dose of parasite (Table 2) .
Irradiation or cyclophosphamide treatment of BCG-infected mice. In two experiments four mice that had received 2 x 107 BCG 30 days earlier and four untreated mice were irradiated with 650 or 900 rad. On the following day these mice, together with four that had received BCG only and four controls, were given 109 B. microti. Neither dose of irradiation (Fig. 6) nor an injection i.p. with cyclophosphamide at a dose of 300 mg/kg (Fig. 7) made BCG-infected mice susceptible to babesiosis (Fig. 7) . If, on the other hand, a dose of 650 rad was given 2 days after the BCG, the protection against 108 B. microti injected 12 days later was abrogated (Fig. 8 ). There were five mice in each group in this experiment. The route of injection of BCG and the short interval before giving this number of parasites account for the relatively high parasitemia in the protected group.
Sensitivity to hydrocortisone. Two groups of four mice received 2 x 107 BCG, and 85 days later these animals and controls were given 106 B. microti. The following day and every 4th day for the duration of the experiment the mice in one of the BCG-infected groups were injected i.p. with hydrocortisone acetate at a dose of 100 mg/kg. This resulted in recrudescence of the parasite (Fig. 9) .
Thymus independence of protection. To ascertain whether T cells are necessary for BCG to protect mice from B. microti, seven congeni- tally athymic "nude" mice, four mice thymectomized as adults (ATx) 4 months previously, and four intact mice were given 2 x 107 BCG, and 14 days later the mice were challenged with 106 B. microti. All groups were protected compared with controls that had not received BCG, though the protection was not as good in the nude mice as in the intact or ATx mice (Fig.  10 (Fig. 3) and durable (Fig. 2) as that after natural recovery. Resistance of BCGinfected animals to a variety of infectious agents has often been attributed to enhanced specific immune responses or increased phagocytic capacity, but our results indicate that neither plays a major role againstBabesia species.
Clearly, this protection cannot be due to the adjuvant effect (9) of BCG on antibody production, since many B. microti die within 24 h of injection into BCG-infected mice (Table 2) , too soon for an appreciable specific response to have been mounted (33) . This occurs even when which had been splenectomized 28 days earlier, were given 2 x 107 BCG. Fourteen days later all 12 and 4 controls were given 106 B. microti. Four of the eight intact BCG-infected mice were splenectomized 9 days after infection with B. microti. Splenectomy before BCG did not remove subsequent protection, but splenectomy after protection had been achieved caused a temporary recrudescence of the parasites (Fig.  11) , as it does in mice protected with C. parvum (unpublished data) and in animals previously recovered from babesiosis (21) . The time of onset of recrudescence in this group spanned 8 days, but, in order to demonstrate the mean peak recrudescence, all four were regarded as having risen synchronously with the first infection to become patent. DISCUSSION Prior infection of mice with BCG confers pro- a dose of 650 or 900 rad, which completely inhibits antibody production (32) , has been given 24 h before infection with the parasite (Fig. 6) . In contrast, the removal of protection by 650 rad given 2 days after the BCG and 12 days before the parasite (Fig. 8) clearly indicates that cell proliferation with no specificity for Babesia species is essential. In addition, BCG given during the prepatent period, when it would have had ample time to exert adjuvanticity, does not protect (Table 1) . Moreover, negligible amounts of antibody specific for B. microti surface antigens, as detected by an indirect fluorescence test, are present in the serum of mice protected against this parasite by either BCG (4) or C. parvum (I. A. Clark, F. E. G. Cox, and A. C. Allison, Parasitology, in press). Our inability to detect cross-reacting antibodies agrees with the findings of workers who have investigated the protective effect of BCG against toxoplasmic retinochoroiditis (31) and of BCG (30) and C. parvum (6) against salmonellosis.
Although injection with BCG increases the rate of carbon clearance in mice (2), increased phagocytic capacity is an equally unlikely explanation for the protection observed. Parasites were not detected in monocytes or macrophages, but dead or dying forms were present in circulating erythrocytes in sufficient numbers (Table 2) to account for the observed decrease in parasitemia. In addition, the BCGinduced increase in carbon clearance of mice reaches its maximum 2 weeks after i.v. injection of the bacteria and then declines (12) , whereas protection against a first challenge with Babesia species is fully maintained for up to 6 months after BCG has been given (Table 1) and for at least 10 months with repeated challenges (Fig. 2) . These results are consistent with the lack of correlation between the ability of BCG and other agents to protect mice against Mengo virus and to increase their phagocytic capacity (18) .
Since babesias are evidently dying outside macrophages, without the mediation of specific antibodies, one is forced to the conclusion that a nonspecific mediator is involved. It is known that such mediators, elicited from mice infected with BCG (25) , can suppress the growth of not only bacteria, a yeast, and bone marrow cells (23) but also a mouse sarcoma (26) . We have found that suppression of B. microti is much greater when BCG is given i.v. than s.c. (Fig. 1) . Hence, the observation (24) that i.v. BCG leads to release of these mediators much more efficiently than when it is given s.c. supports the view that we may be observing another manifestation of the same phenomenon.
Several workers have suggested that BCG and C. parvum may suppress tumor growth by the same mechanism (15, 27) . Comparison of protection against Babesia species induced by BCG and C. parvum (Clark et al., Parasitology, in press) and inhibition of certain tumors by these agents reveals some striking similarities: i.v. injection protects more efficiently in vivo (19; Fig. 1 ), and also endows macrophages with much greater in vitro cytostatic activity against tumors, than does s.c. injection (13); splenectomy after injection, but not beforehand, temporarily interferes with protection (15; Fig. 11 ); mice deprived of T lymphocytes are protected (28, 35; Fig. 10) ; and protection is resistant to radiation (16; Fig. 6 ) and cyclophosphamide (28; Fig. 7 ) but sensitive to cortisone (29; Fig. 9 ). Finally, there is now evidence that restriction of tumor growth by BCG may be mediated by soluble factors (3, 17, 26) . The intra-erythrocytic death of B. microti leads us to the same conclusion for these parasites.
The results presented in this paper indicate that babesias in mice are particularly susceptible to nonspecific immunity, which BCG can induce against a range of infectious agents and tumors. This observation, as well as the large size ofthe parasite and its location inside erythrocytes, allowing rapid sampling and assessment, gives this model particular advantages for further elucidation of the way in which the widespread protective mechanism induced by BCG exerts its effects.
Moreover, BCG-induced protection against Babesia species and specific immunity to this parasite in mice may have the same final mediator, since the protection in each case is equally intense and durable, is effective against the same range of blood protozoa, and leads to intra-erythrocytic death of the parasite with very similar ultrastructural changes.
